A Piga, R Galanello, GL Forni, MD Cappellini, R Origa, A Zappu, G Donato, E Bordone, A Lavagetto, L Zanaboni, R Sechaud, N Hewson, JM Ford, H Opitz, D Alberti. Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload. Haematologica 2006;91(7):873-880; https://doi.org/10.3324/%x.